The Office of Foreign Assets Control sanctioned people and entities in Uganda, Iran and Syria for human rights abuses or for undermining democratic institutions. The designations target military or government officials in all three countries as well as two Iranian law enforcement agencies and two Iranian prisons, OFAC said Dec. 7. The U.S. purposefully issued the sanctions just ahead of its democracy summit later this week, which will convene more than 100 of the world’s democracies to discuss collaboration on human rights issues, anti-corruption and more. “Consistent with the goals of this week’s Summit for Democracy, the United States is committed to using its full range of tools to counter serious human rights abuse and repressive acts across the world,” Secretary of State Antony Blinken said.
Export Compliance Daily is providing readers with the top stories for Nov. 29 - Dec. 3 in case you missed them. You can find any article by searching the title or by clicking on the hyperlinked reference number.
The U.S.’s new anti-corruption strategy, coupled with its democracy summit later this week, could convince more allies to adopt Global Magnitsky sanctions regimes, former U.S. officials said. They said the administration’s plans to pursue more multilateral sanctions and trade restrictions at the summit could build a more united front to address global corruption and human rights abuses.
The EU General Court issued judgments Nov. 24 in four Syria sanctions annulment applications. The court annulled Bashar Assi's and Khaldoun Al Zoubi's listings, noting the EU had failed to show that either man was a leading businessperson or associated with the regime when the sanctions acts were enacted, the opinion said.
The Drug Enforcement Administration is proposing to list methoxetamine (MXE), a member of the arylcyclohexylamine class of drugs with dissociative anesthetic and hallucinogenic properties, similar to phencyclidine (PCP) and ketamine, under Schedule I of the Controlled Substances Act, it said in a notice released Dec. 6. “If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle, methoxetamine.” Comments are due by Feb. 7.
The Office of Foreign Assets Control sanctioned Alain Mukonda and 12 companies linked to Mukonda for providing support to sanctioned billionaire Dan Gertler, OFAC said Dec. 6. Mukonda and the companies are based in the Democratic Republic of the Congo.
Iran hasn’t offered “serious” proposals to return to the Iranian nuclear deal and has continued to accelerate its nuclear program despite objections from the U.S. and other countries, a senior State Department official said. The official, speaking to reporters Dec. 4, suggested the latest round of talks to rejoin the Joint Comprehensive Plan of Action ended poorly after Iran demanded too many concessions and offered too little in return.
The Biden administration unveiled a new strategy to counter corruption, and officials said they are planning new sanctions in the coming days to target corrupt actors and other international criminals. As part of the strategy, which came after a 200-day review by federal agencies to determine how the U.S. can better curb illicit finance, the administration will increase anti-corruption work at the Treasury, State and Commerce departments, according to a Dec. 6 White House fact sheet. The U.S. also will take “meaningful steps” to stop corrupt actors from using the U.S. and the international financial systems.
FDA is recommending that exporters of certain food products to China provide the agency with facility information by Dec. 17 to avoid a potential trade disruption from the entry into effect of Chinese food facility requirements on Jan. 1, it said. While FDA continues to engage China’s General Administration of Customs (GACC) on the potential for self-registration of U.S. exporters to China, FDA says it still has yet to receive a satisfactory response and may be required to submit exporter registration data to China at the beginning of the new year.
The Commerce Department will soon launch a new feature to automatically warn filers if they are exporting a controlled item without a license, an improvement the agency hopes leads to better due diligence among exporters. The agency will deploy the Automated Export System feature Jan. 13, 2022, the Census Bureau said in a Dec. 6 email to industry. The announcement has been expected since October (see 2110180027). The new feature will alert exporters that incorrectly list License Requirement NLR (No License Required) for shipments that require a license under the Export Administration Regulations. The message will appear with the response code 66Q and will serve as a warning message to filers for the first six months after the Jan. 13 effective date, Census said. After the six-month period, the agency will upgrade the warning to a “fatal” error, which will block the exporter from moving forward with the filing. Exporters having difficulties with the error message or reporting their information correctly but still receiving the message should email the Bureau of Industry and Security at ECDOEXS@bis.doc.gov, Census said. Exporters should ask about the Export Control Classification Number associated with their export and any other “additional licensing authorization that may be required,” Census said.